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The thymus is considered to play an important role in the pathogenesis of Myasthenia gravis,
an autoimmune disease characterized by antibody-mediated skeletal muscle weakness. However, its
role is yet to be deﬁned. The studies described herein summarize our efforts to determine how
intrathymic expression of the neuromuscular type of acetylcholine (ACh) receptors is involved in the
immunopathogenesis of this autoimmune disease. We review the work characterizing the expression of
neuromuscular ACh receptors in the thymus and advance a new hypothesis that examines the
intrathymic expression of this autoantigen in disease pathogenesis.
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INTRODUCTION
Myasthenia gravis (MG) is a disease characterized by
weakness of striated muscles. The weakness is due to
impaired neuromuscular transmission resulting from a
reduction of the number of receptors for the neurotrans-
mitter, acetylcholine (ACh) at the postsynaptic myoneural
junction. This reduction is caused by the action of anti-
acetylcholine receptor (anti-AChR) antibodies, reviewed
in Levinson et al. (1987). MG is a prototypic autoimmune
disease; the immune effector mechanisms and autoanti-
genic target have been delineated. However, the events
leading to the abrogation of self-tolerance to the
neuromuscular type of AChR (nAChR) remain a mystery.
The thymus gland has long been considered to hold the
key to solving this mystery, although the nature of its
involvement remains to be elucidated.
Interest in a pathogenic role for the thymus in MG has
been fueled by pathologic, clinical and immunologic lines
of evidence as reviewed by Levinson and Wheatley
(1995). Brieﬂy, thymus glands of 60–70% of MG patients
demonstrate the histological pattern of germinal center
hyperplasia whereas another 10% display cortical
epithelial cell thymomas. Thymectomy, particularly in
young patients (,40 years of age) with thymic
hyperplasia, is followed by clinical improvement and
remains a ﬁrst-line therapeutic intervention. nAChR-
speciﬁc B and T cells have been recovered from MG
thymus specimens but not control thymus tissue. This
indicates that the autoimmune effector cells populate
the diseased thymus.
EXPRESSION OF nAChR IN THYMUS
A major feature of the thymus that very likely represents
an important pathogenic link to MG is the expression of
nAChRs on cells in this organ as reviewed in Levinson and
Wheatley (1995). The issue of thymic expression of AChR
has attracted considerable interest, in part, because of the
pivotal role that self-antigen expression in the thymus
plays in tailoring the T cell repertoire. Moreover, the
expression of nAChRS on thymic cells represents the ﬁrst
description of the “promiscuous” intrathymic expression
of an organ-speciﬁc self-antigen that is the target of an
autoimmune attack in the periphery. The early reports
prompted some investigators to propose that the thymus
might actually serve as a site of sensitization for this
autoantigen (Wekerle et al., 1978). Taken at face value,
this idea might be viewed as being incongruent with the
cardinal immunologic construct, noted above, namely that
thymic self-proteins, particularly those expressed on
epithelial cells orchestrate the induction of self-tolerance
(Klein and Kyewski, 2000).
The nAChRs are expressed in two major forms as
reviewed in Levinson (2001a). The so-called mature or
junctional form is expressed on innervated muscles and
the immature or fetal form is expressed on non-innervated
tissue. At the mature (innervated) myoneural junction,
nAChRs are comprised of four subunits labeled a, b, d
and 1. Two alpha subunits and one each of the other
subunits are assembled, like the whalebone in a corset, to
form an asymmetric hourglass channel spanning the
membrane. Two alternatively spliced alpha subunit
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þ isoform, which includes an additional
sequence of 25 amino acids between exons 3 and 4, is
found only in humans and other primates. In fetal muscle,
as in adult denervated muscle or nonjunctional membrane,
a g subunit replaces the 1 subunit found in mature,
innervated muscle endplates.
In the analysis of nAChRs in the thymus, many
investigators have focused on the nAChR alpha subunit
(nAChRa)sinceitisthesourceoftheimportantpathogenic
T and B cell epitopes for the pathogenic autoimmune
response in MG (Oshima et al., 1990; Zhang et al., 1990;
Conti-Fine et al., 1998; Fuji and Lindstrom, 1988).
Expression of this subunit was originally reported on a
variety of thymic cells including epithelial cells (Engel
et al., 1977), thymocytes (Fuchs et al., 1980), and myoid
cells (Kao and Drachman, 1977; Schluep et al., 1987).
Myoid cells, which share phenotypic properties with
skeletal muscle cells, were originally viewed as the
principalAChR-expressing cells inthymus(Schluepetal.,
1987). They are found in the medulla of both normal and
MG thymus.
In the past several years, there has been renewed interest
in thymic cells as a source of nAChR expression. Several
investigators, including ourselves, have taken a molecular
approach in characterizing thymic AChRs and identifying
cell populations expressing them. Using reverse-transcrip-
tion-PCR (RT-PCR) technology, we reported that mRNA
for the AChRa was expressed in normal mouse
(Wheatley et al., 1992), normal human and MG thymus
(Wheatley et al., 1993; Zheng et al., 1999). We also
reported that AChRa mRNA was expressed on trans-
formed murine thymic cortical and medullary epithelial
cell lines and thymic dendritic cell lines (Wheatley et al.,
1992). We found that mRNAs encoding both major
isoforms of the human AChRa, i.e. P3A
þ and P3A
2, were
expressed in normal and MG thymus and normal human
thymic epithelialcells(Wheatley etal.,1993; Zheng etal.,
1999). Sequencing of P3A
þ and P3A
2 cDNA clones
recovered from control and MG thymus indicated that
they share the same nucleotide sequence as their
respective counterparts at the myoneural junction. Thus,
unless there are posttranslational changes, the structure of
the AChRa proteins expressed in the thymus and the
periphery are likely to be identical. These results provided
a structural basis for proposing that an immune response
directed at thymic nAChRa may be responsible for
initiating or perpetuating disease. Berrih-Aknin sub-
sequently reported that AChRa protein as well as mRNA
was expressed on human thymic epithelial cells (Wakkach
et al., 1978).
However, there is still a controversy over the expression
of the other subunits on thymic cells and whether they are
expressed as components of intact receptors. Some of the
reported discrepancies may reﬂect differences in the ages
of the thymus donors and differences in the design of the
RT-PCRs. At this time, it appears as if 1 and b mRNAs are
expressed in most normal and MG thymus specimens with
variable expression of d and g subunits (Naveneetham
et al., 2001; Bruno et al., 2004). Expression of the AChR
subunits appears to be concentrated in the thymic
medullary compartment.
To gain a better understanding of how intrathymic
expressionofnAChRamightbelinkedtothedevelopment
of disease, we addressed additional features of nAChRa
expression in the thymus. We observed that the smaller
P3A
2 isoform is present in approximately a ﬁve-fold
excess in both MG and control thymictissue and a 2.5-fold
excess in a non-transformed human thymic epithelial cell
(TEC) line relative to the larger P3A
þ isoform (Fig. 1)
(Zheng et al., 1999). The greater expression of the P3A
2
isoform in thymus does not parallel its expression in
healthy and MG muscle tissue where both isoforms show
equivalent expression (Beeson et al., 1990). These
observations suggest that the expression of mRNAs
encoding the P3A
2 and P3A
þ isoforms is regulated
differently in human thymus and muscle. Since the same
disproportionate expression of P3A
2 was observed in
control and MG thymus, it appears that the differential
patternofexpressionobservedinthymusrelativetomuscle
is not a manifestation of thymic pathology in MG. Rather,
this pattern may reﬂect control processes that are unique to
these two distinct tissue compartments. Presently, it is not
known whether the disproportionate expression of P3A
2
vs. P3A
þ isoforms has pathogenic signiﬁcance.
We also observed that expression of both P3A
þ and
P3A
2 mRNAs are increased in MG thymus compared to
control thymus (Fig. 2) (Zheng et al., 1999). This ﬁnding
parallels that reported for skeletal muscle where AChR
mRNA expression was found to be greater in MG muscle
than in control muscle (Guyon et al., 1993). The ﬁnding of
increased AChRa mRNA expression in MG thymus may
represent an attempt to compensate for the destructive
action of locally secreted anti-AChR antibodies. It is also
possible that the increased AChR mRNA expression may
reﬂect the antecedent action of other local environmental
factors, e.g. cytokines.
FIGURE 1 Relative expression of AChRa P3A
2 and P3A
þ isoforms in
thymus and TEC. Compilation of data from 14 MG thymuses, 7 control
thymuses,and 4 separate TEC experiments.The signals forthe P3A
2 and
P3A
þ bands on Southern blots were quantitated on a phosphorimager.
The P3A
2/P3A
þ ratios are shown. Expression of P3A
2 exceeded that of
P3A
þ by a factor of 5.5 ^ 0.9 (mean ^ SEM) in Control thymus,
4.7 ^ 0.05 in MG thymus, and 2.8 ^ 0.2 in TEC. (Copyright: Clinical
Immunology, 1:1999).
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EXPRESSION
IL-1 and IL-6 production by epithelial cells is increased in
hyperplastic thymic tissue obtained from MG patients
compared to thymus from control subjects (Cohen-
Kaminsky et al., 1978; Emilie et al., 1991). Since
cytokines produced in vitro by thymic epithelial cell
(TEC) lines demonstrate autocrine function (Galy and
Spits, 1991), it seemed plausible that these cytokines or
perhaps others produced by cells in the thymus might
regulate TEC expression of AChR. We examined this
possibility by incubating a human non-transformed TEC
line with either IL-1b, IL-4, IL-6 and interferon-g
(IFN-g). We found that neither IL-1, IL-4, nor IL-6
altered the expression of AChRa mRNA by this cell line
(Zheng et al., 1999). By contrast, IFN-g increased
expression of the P3A
2 and P3A
þ isoforms by factors of
2.7 and 2.8, respectively. It is known that IFN-g
up-regulates the expression of MHC class II antigens on
thymic epithelial cells (Berrih-Aknin et al., 1985; Galy
and Spits, 1991). This dual effect of IFN-g on AChRa and
MHC antigens raises the possibility that this cytokine, and
perhaps others, may alter expression of thymic AChRa
in vivo in a manner that leads to the development or
perpetuation of MG. Before addressing this idea, it would
be helpful to brieﬂy review the role of self-antigen
expression in thymus plays in the development of T cell
tolerance and consider how the thymus could serve as a
site of immune activation.
INTRATHYMIC EXPRESSION OF SELF
ANTIGEN AND THE DEVELOPMENT OF
T CELL TOLERANCE
The thymus plays a fundamental role in the generation of
the peripheral T cell repertoire as reviewed in Klein and
Kyewski (2000), Sprent et al. (1988), Kisielow and
Boehmer (1990), Alam et al. (1996) and Anderson et al.
(1996). It is generally believed that thymocytes with low
afﬁnity receptors for self are positively selected for export
tothe peripherallymphoid tissues where they comprisethe
T cell repertoire that recognizes exogenous antigens
(Kisielow and Boehmer, 1990; Anderson et al., 1996).
Bycontrast,Tcelltolerancetoselfiseffectedlargelybythe
process of central deletion/inactivation. Developing
thymocytes with high afﬁnity receptors for self-peptide
are silenced by apoptosis or anergy. There is widespread
agreement that presentation of self-peptides by cortical
epithelial cells is necessary for positive selection
(Kisielow and Boehmer, 1990; Alam et al., 1996;
Anderson et al., 1996). Thymic medullary epithelial cells
and to a lesser extent, bone marrow-derived macrophages
and dendritic are considered to be the major APCs
involved in negative selection (Blackman et al., 1990;
Bonomo and Matzinger, 1993; Hugo et al., 1994;
Hoffmann et al., 1995; Klein and Kyewski, 2000).
However, central deletion is not complete even though a
broad array of self-peptides is “promiscuously” expressed
on medullary thymic epithelial cells (Klein and Kyewski,
2000). Self-reactive T cells escape from the thymus in
small numbers, perhaps due to the fact that limiting levels
of self-antigen limit the efﬁciency of tolerance induction
(Adelstein et al., 1991; Iwabuchi et al., 1992; Oehen et al.,
1994). However, such self-reactive T cells are silenced by
their anergic or ignorant status, i.e. they never encounter
self-antigen in the periphery in a manner that leads to
immune activation, or they are suppressed by regulatory
T cells (Shevach, 2000).
FIGURE 2 Semiquantitative RT-PCR: compilation of results from
thymus specimens of seven control subjects and fourteen MG patients.
The signal intensity of the AChRa bands is normalized to the signal
intensity of the standard by calculating the ratio of thymic
AChRa/AChRa standard. The expression of P3A
2 and P3A
þ isoforms
in MG thymus is 2.5- and 2.8-fold greater, respectively, than that in
control thymus. (Copyright: Clinical Immunology, 1:1999).
FIGURE 3 Semiquantitative RT-PCR: compilation of results from six
TEC experiments depicting the effect of IFN-g on expression of AChRa
isoforms in TEC. To determine the effect of IFN-g on the expression of
AChRa P3A
2 and P3A
þ isoforms, we compared the normalized signal
intensities of the isoforms (ratio of thymic AChRa/AChRa standard)
detected in untreated and IFN-g treated TEC9 cultures. Expression of
P3A
2 mRNA was signiﬁcantly greater in IFN-g treated (2.19 ^ 0.75,
mean þ SEM) than in untreated cultures (0.89 ^ 0.36, p , 0:05;
student’s t-test). Likewise, expression of P3A
þ mRNA was
signiﬁcantly greater in IFN-g treated (0.9 ^ 0.31) than in untreated
cultures (0.36 ^ 0.15, p , 0:05). (Copyright: Clinical Immunology,
1:1999).
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Based on the classic studies of Gowans, trafﬁc of
lymphocytes is generally considered to be unidirectional,
i.e. out of the thymus into the blood and peripheral
lymphoid organs (Gowans and Knight, 1964). However,
small numbers of peripheral immunocompetent T cells
migrate to the thymus, entering via the medulla
(Naparstek et al., 1982,1993; Michie et al., 1988;
Hirokawa et al., 1989; Agus et al., 1991; Gossmann
et al., 1991; Westermann et al., 1991). Most of the thymic
immigrants are T cells activated in the peripheral immune
system although even resting T cells may gain access to
the thymus (Hirokawa et al., 1989; Agus et al., 1991;
Gossmann et al., 1991; Westermann et al., 1991). It is not
known if the rate or number of thymic immigrants is
increased by an inﬂammatory reaction in the thymus.
Furthermore, it is not known if self-reactive T cell
immigrants are activated when they encounter their
speciﬁc antigens in the thymus. Thymus T cell immigrants
speciﬁc for the lymphocytic choriomeningitis virus
(LCMV) clear infectious foci from the thymus (Gossmann
et al., 1991). This observation indicates that peripheral T
cells can be activated when they engage speciﬁc foreign
antigens in the thymus in an appropriate context. When
self-reactive T cells encounter their antigens in other
tissue compartments in the presence of requisite
co-stimulatory signals, they can be activated to express
their differentiation program, reviewed in Mondino et al.
(1996). One mechanism that leads to a milieu that
promotes the abrogation of tolerance peripherally is
infection. Local infection can lead to the upregulation of
MHC antigens and co-stimulatory molecules on cells that
express low levels of self-antigens and thereby lead to
activation of autoreactive T cells (Mondino et al., 1996).
A NEW MODEL OF THYMIC INFLAMMATION
AND ITS IMPACT ON “RETROGRADE” T CELL
MIGRATION
Delineation of the molecular events, particularly in the
thymus, that trigger MG has been hampered by the lack of
a model system. Thymic pathology is not a feature of
experimental models of MG in rodents. Although such
models have provided insight into the pathogenesis of
MG, they have not served to elucidate the role played by
the thymus (Christadoss et al., 2000). To address this issue
we have developed a model of inﬂammation targeted to
the thymic medulla, the site of thymic entry by peripheral
T cells (Levinson et al., 2001b). We generated molecular
variants of the well characterized thymotrophic Gross
murine leukemia virus (G-MLV), GD17, that had
previously been shown to exclusively infect medullary
thymic epithelium following their intrathymic injection in
naı ¨ve mice. The variants were constructed to allow for
easy casetting of a broad array of genes of interest. The
thymo-tropic MLV vectors were created by ligating a
425bp fragment containing the U3 region of GD-17 into
the LTR backbone of the well deﬁned M-MLV vector
LXSH.
The vectors used in our studies are presented in
linear form in Fig. 4. The parental LXSH vector includes
50 M-MSV LTR, the psi packaging site and 50 gag
region, the hygromycin resistance gene under control of
the SV40 promoter, and the 30 LTR of M-MLV. For our
experimental protocol, we modiﬁed this vector by
insertion of the Lac z gene (LBSHG). We utilized
LBSHG and LXSHG as our experimental and control
vectors, respectively. As was true for GD17, we found that
these vectors also target expression of encoded genes to
the thymic medullary epithelium.
Balb/c mice were immunized to b-galactosidase (b-gal)
and then injected intrathymically (i.t.) with the b-gal
encoding vector LBSHG or the control vector LXSHG.
Hematoxylin and eosin stained sections of thymus
obtained four days after i.t. injection of LBSHG, but not
LXSHG, showed obliteration of the cortical/medullary
architecture with marked cellular expansion of the
medulla. To determine whether this local inﬂammatory
reaction non-speciﬁcally augmented the entry of peri-
pheral T cells into the thymus, b-gal immunized mice
were injected i.v. with a population of CFSE-labeled
CD4þ T cells speciﬁc for an unrelated antigen
four days after i.t. injection of LBSHG or LXSHG. The
CD4þ T cells were derived from a transgenic mouse
FIGURE 4 SchematicdiagramofMLV-basedvectors.Thevectorsusedinthesestudiesarepresentedinlinearform.TheparentalLXSHvectorincludes
the50 M-MCVLTR,thepsipackagingsiteandthe50 gagregion,thehygromycinresistancegeneunderthecontroloftheSV40promoter,andthe30 LTR of
M-MLV. Vectors are modiﬁed by insertion of either GD-17 U3 or LacZ. (Copyright: Annals of the New York Academy of Sciences, 998:2003).
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hemagglutinin peptide. Animals that receivedLBSHG had
4.2-fold more CFSE-labeled CD4þ thymic immigrants
than animals that received the control vector.
Using this model, we have begun to examine a new
hypothesisbearingontheintrathymicpathogenesisofMG.
(Fig. 5). The hypothesis posits that an inﬂammatory
reaction to an unrelated antigen within the medulla of the
thymus facilitates entry of peripheral AChRa-reactive
CD4þ T cells that escaped central deletion. These cells
enterthethymusinthemedullarycompartmentwherethey
encounter AChRa expressed on antigen presenting cells.
The concomitant intrathymic inﬂammatory reaction
creates a milieu that favors activation of these cells, i.e.
upregulation of MHC class II antigens, co-stimulatory
molecules on APCs, and perhaps upregulation of
AChR expression. Presentation of AChRa epitopes to the
CD4þ thymicimmigrantsleadstotheiractivation,helpfor
locally stimulated aAChR-reactive B cells, the production
of anti-AChR antibodies,and the development ofMG.The
rationale for this hypothesis is outlined in Table I.
CONCLUSION
There is considerable circumstantial evidence that the
thymus plays a pivotal role in the pathogenesis of MG.
Nevertheless, the pathogenic link remains to be forged.
We are re-examining the hypothesis that AChR expressed
in the thymus drivesthe pathogenic autoimmune response.
We have established a model of intrathymic inﬂammation
that is localized to the thymic medulla and demonstrated
that such an inﬂammatory process promotes the
nonspeciﬁc entry of peripheral CD4þ T cells into the
thymus. We are currently exploiting this model to
determine whether (1) AChR-reactive CD4þ T cell
homing to the thymus is also augmented by a concurrent
intrathymic inﬂammatory response to an unrelated antigen
and (2) AChR-reactive T cell immigrants undergo
activation following their engagement of autoantigen in
this inﬂammatory milieu, provide help for the production
of anti-AChR antibodies by immigrant autoreactive B
cells, and thereby promote the development of a
myasthenic syndrome.
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